Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591953 · ClinicalTrials.gov registry record · NA
Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02591953: Clinical Trial NA study, sponsored by Rush University Medical Center.
NCT02591953 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02591953, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Using randomization, prospectively determine superiority of either ultrasound-guided or landmark-guided biceps corticosteroid injections with regard to various clinical variables.
Primary Outcome
12 question assessment of shoulder function with yes or no answers
Interventions
- DRUG Methylprednisolone
- DRUG Lidocaine 1%
- PROCEDURE Ultrasound-guidance
- PROCEDURE Landmark-guidance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-05 |
| Phase | NA |
Why NCT02591953 stopped before completion
NCT02591953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Methylprednisolone is the first listed.
NCT02591953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02591953 about?
NCT02591953 is a clinical study titled "Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections". Using randomization, prospectively determine superiority of either ultrasound-guided or landmark-guided biceps corticosteroid injections with regard to various clinical variables.
What is the current status of trial NCT02591953?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2015-11. Estimated completion is 2019-05.
What interventions are being tested in trial NCT02591953?
The interventions under investigation include: Methylprednisolone (DRUG), Lidocaine 1% (DRUG), Ultrasound-guidance (PROCEDURE), Landmark-guidance (PROCEDURE).
Who is sponsoring clinical trial NCT02591953?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02591953's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia